Irina Antonijevic
Direktor/Vorstandsmitglied bei 4SC AG
Vermögen: 88 979 $ am 31.05.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Julia Gregory | F | 71 | 7 Jahre | |
| Vladimir Coric | M | 53 | 9 Jahre | |
| Gregory Bailey | M | 68 | 10 Jahre | |
| John Childs | M | 81 | 10 Jahre | |
| Robert Hugin | M | 69 | 4 Jahre | |
| George Clark | M | - | 5 Jahre | |
| Michael Heffernan | M | 59 | 4 Jahre | |
| Kishan Mehta | M | 38 | 3 Jahre | |
| Kathleen Masch-Wiest | F | - | 2 Jahre | |
| Kimberly Gentile | F | 56 | 9 Jahre | |
| Douglas G. Gray | M | - | - | |
| Clemens M. Doppler | M | 64 |
Verinos Pharmaceuticals GmbH
| 19 Jahre |
| Matthew Buten | M | 62 | 3 Jahre | |
| Megan M. Dow | M | - | 4 Jahre | |
| Barbara Douglas | F | - |
EveryONE Medicines, Inc.
 EveryONE Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services EveryONE Medicines, Inc. delivers individualized precision therapeutics customized to the unique pathogenic genetic mutation of patients. EveryONE Medicines is based in Boston, MA. The company's goal is to provide quality of life to patients by slowing or even halting their disease. The company was founded by Julia Vitarello and Keith Flanagan. The CEO is Nessan Bermingham. | - |
| Gastón Ortega | M | - | 2 Jahre | |
| Paloma Moraleda | F | - | 2 Jahre | |
| Irfan Qureshi | M | - | - | |
| Michael Schlenk | M | - | 2 Jahre | |
| Keith Flanagan | M | - |
EveryONE Medicines, Inc.
EveryONE Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services EveryONE Medicines, Inc. delivers individualized precision therapeutics customized to the unique pathogenic genetic mutation of patients. EveryONE Medicines is based in Boston, MA. The company's goal is to provide quality of life to patients by slowing or even halting their disease. The company was founded by Julia Vitarello and Keith Flanagan. The CEO is Nessan Bermingham. | - |
| Clifford Bechtold | M | - | - | |
| Warren Volles | M | - | - | |
| Hans Tanner | M | 73 | 7 Jahre | |
| Nick Kozauer | M | - | 1 Jahre | |
| Jason Loveridge | M | 63 | 8 Jahre | |
| Helga Rübsamen-Schaeff | M | 75 | 9 Jahre | |
| Helmut Jeggle | M | 53 | 16 Jahre | |
| Chris Barrett | M | - | - | |
| Tim Allsopp | M | - |
The University of Edinburgh
| 30 Jahre |
| Jennifer Porcelli | F | - | 2 Jahre | |
| David Saunders | M | - | - | |
| Rachel McMinn | M | 51 |
EveryONE Medicines, Inc.
EveryONE Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services EveryONE Medicines, Inc. delivers individualized precision therapeutics customized to the unique pathogenic genetic mutation of patients. EveryONE Medicines is based in Boston, MA. The company's goal is to provide quality of life to patients by slowing or even halting their disease. The company was founded by Julia Vitarello and Keith Flanagan. The CEO is Nessan Bermingham. | 3 Jahre |
| Nessan Bermingham | M | 51 |
EveryONE Medicines, Inc.
EveryONE Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services EveryONE Medicines, Inc. delivers individualized precision therapeutics customized to the unique pathogenic genetic mutation of patients. EveryONE Medicines is based in Boston, MA. The company's goal is to provide quality of life to patients by slowing or even halting their disease. The company was founded by Julia Vitarello and Keith Flanagan. The CEO is Nessan Bermingham. | 2 Jahre |
| Lisa Stocking | F | - | - | |
| Jon Blaskovich | M | - | - | |
| Maryellen McQuade | F | - | - | |
| Bruce Car | M | 61 | 2 Jahre | |
| Horst Wildemann | M | 82 |
Technische Universität München
| 36 Jahre |
| Caroline Dircks | M | - | 4 Jahre | |
| Markus Guilherme Dieken | M | - | 5 Jahre | |
| Manfred Rüdiger | M | 59 | 19 Jahre | |
| Susanne Danhauser-Riedl | M | - | 9 Jahre | |
| Julian Baker | M | 57 |
EveryONE Medicines, Inc.
EveryONE Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services EveryONE Medicines, Inc. delivers individualized precision therapeutics customized to the unique pathogenic genetic mutation of patients. EveryONE Medicines is based in Boston, MA. The company's goal is to provide quality of life to patients by slowing or even halting their disease. The company was founded by Julia Vitarello and Keith Flanagan. The CEO is Nessan Bermingham. | - |
| Melissa Beiner | M | - | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Henri A. Termeer | M | 78 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 28 Jahre |
| Ralph Lassig | M | - |
Technische Universität München
| 12 Jahre |
| Elyse Stock | M | 66 | 5 Jahre | |
| Christopher Viehbacher | M | 64 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Elisabetta Castiglioni | M | 59 |
Technische Universität München
| 4 Jahre |
| Andreas Schaller | M | - |
Technische Universität München
| 6 Jahre |
| William Sibold | M | 57 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Linda Bain | F | 53 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 3 Jahre |
| Yamo Deniz | M | 60 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 4 Jahre |
| Gabriele Sommer | F | 60 |
Technische Universität München
| 6 Jahre |
| Gloria Matthews | M | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 6 Jahre |
| Peter Heinold | M | - |
Technische Universität München
| 5 Jahre |
| Anna Niedl | M | - | 2 Jahre | |
| Frank Hermann | M | - | - | |
| Charles Conway | M | 62 | 5 Jahre | |
| John Tilton | M | 56 | 6 Jahre | |
| Josias Fantato De Pontes | M | 58 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Christian Kohlpaintner | M | 61 |
Technische Universität München
| 8 Jahre |
| Michael Wyzga | M | 69 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 13 Jahre |
| Enno Spillner | M | 55 | 11 Jahre | |
| Alan Smith | M | 78 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 22 Jahre |
| Ilham Akbar Habibie | M | 61 |
Technische Universität München
| 8 Jahre |
| Wolfgang Söhngen | M | - | 19 Jahre | |
| Ulrich Dauer | M | 59 | 16 Jahre | |
| Daniel Vitt | M | 55 | 19 Jahre | |
| Peter Wirth | M | 73 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 15 Jahre |
| Roger W. Louis | M | 69 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 15 Jahre |
| Stefan Weingartner | M | 63 |
Technische Universität München
| 4 Jahre |
| Alvin Loh | M | - |
The University of Edinburgh
| 4 Jahre |
| Markus H. Thoma | M | 66 |
Technische Universität München
| 3 Jahre |
| Johannes Schmidt | M | - |
Technische Universität München
| 4 Jahre |
| Raimund Klinkner | M | 59 |
Technische Universität München
| 6 Jahre |
| Werner J. Bauer | M | 73 |
Technische Universität München
| 5 Jahre |
| Maximilian Hardegg | M | 58 |
Technische Universität München
| 4 Jahre |
| Bassam Samir Shehadah Al-Talhouni | M | 60 |
The University of Edinburgh
| 3 Jahre |
| Ricardo Malta | M | 56 |
Technische Universität München
| 4 Jahre |
| Thomas Deisboeck | M | - |
Technische Universität München
| 5 Jahre |
| Marc Hundsdorf | M | 56 |
Technische Universität München
| 5 Jahre |
| Gareth John Rudd | M | - |
The University of Edinburgh
| 1 Jahre |
| Anton Mindl | M | 67 |
Technische Universität München
| 3 Jahre |
| Tarek Kamel | M | 62 |
Technische Universität München
| 3 Jahre |
| Mark Lazarowicz | M | 70 |
The University of Edinburgh
| 3 Jahre |
| Edmund Bellord | M | - |
The University of Edinburgh
| 4 Jahre |
| Georg Koch | M | 61 |
Technische Universität München
| 5 Jahre |
| Erhardt Barth | M | - |
Technische Universität München
| 3 Jahre |
| Werner Lang | M | 56 |
Technische Universität München
| 4 Jahre |
| Alan Ross | M | - |
The University of Edinburgh
| 4 Jahre |
| Jörg Dieter Ulrich | M | - |
Technische Universität München
| 4 Jahre |
| Herbert Diess | M | 65 |
Technische Universität München
| 3 Jahre |
| Volker Kefer | M | 68 |
Technische Universität München
| 3 Jahre |
| Min Wan Ip | M | - |
The University of Edinburgh
| 4 Jahre |
| Roland M. Dürre | M | - |
Technische Universität München
| - |
| Klaus Hollmeier | M | 61 |
Technische Universität München
| 4 Jahre |
| Georg Lingg | M | 60 |
Technische Universität München
| 6 Jahre |
| Gerhard Abstreiter | M | 78 |
Technische Universität München
| - |
| George Crawford | M | - |
The University of Edinburgh
| 4 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 46 | 46,00% |
| Deutschland | 45 | 45,00% |
| Vereinigtes Königreich | 9 | 9,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Irina Antonijevic
- Persönliches Netzwerk